09.01.26 -- Unlocking The Future Of Cell And Gene Therapies

Learn how a comprehensive investigation and systems-level bio-decontamination strategy successfully eliminated persistent mold contamination in a vaccine manufacturing facility's high-risk area.

Aseptic drug manufacturing is going small. Discover how advanced robotic and automated systems with smaller footprints are changing the landscape and boosting accessibility for drug developers.

Personalized cancer vaccines face a DNA production bottleneck. Synthetic approaches speed timelines, boost consistency, and simplify workflows to deliver individualized therapies faster.

CRISPR is transforming medicine, but precision remains critical. Off-target effects pose ongoing safety challenges, driving the need for rigorous, multidimensional evaluation strategies.

AAV gene therapy shedding assays demand matrix-specific extraction and rigorous validation across blood, semen, urine, and saliva. Uncover the strategies that ensure reliable qPCR data across biological matrices.

With continuously evolving gene therapy regulations and guidance and limited time during development for testing, here are four points to consider when planning product-release testing of your gene therapy product.

Discover how leveraging platform processes can enable flexible service at each level – pre-clinical through commercial – and reduce development timelines and costs on the clear path to market.

Ensuring AAV quality starts with payload characterization. Investigate why conventional methods may miss key capsid population insights and how GMP-compliant svAUC provides a better evaluation path.

A robust platform process can help ensure therapeutic efficacy and supply chain security for LVV-based products, as well as support aggressive development and commercialization timelines.

Explore two projects that a focus on improving efficiency and productivity in biopharmaceutical manufacturing while reducing the cost of goods through process intensification.

The membrane filter technique offers a cost‑effective way to detect microbial contamination. See how it enables rapid detection and allows precise species identification using selective media.

Advances in genome engineering and immune evasion are enabling scalable, durable allogeneic cell therapies, overcoming rejection challenges and expanding potential treatments across diverse diseases.

Expert single-use engineers address six common questions posed by cell and gene therapy manufacturers in the design of custom single-use manifolds for the critical handling of biological fluids.